Table: begin end state 1 19 cytoplasmic 20 38 transmembrane 39 57 non-cytoplasmic 58 76 transmembrane 77 93 cytoplasmic 94 111 transmembrane 112 116 non-cytoplasmic 117 136 transmembrane 137 147 cytoplasmic 148 171 transmembrane 172 182 non-cytoplasmic 183 205 transmembrane 206 245 cytoplasmic 246 267 transmembrane 268 281 non-cytoplasmic 282 300 transmembrane 301 311 cytoplasmic 312 331 transmembrane 332 336 non-cytoplasmic 337 359 transmembrane 360 367 cytoplasmic 368 391 transmembrane 392 400 non-cytoplasmic 401 422 transmembrane 423 429 cytoplasmic
Input: >BPHYT_RS30610 FitnessBrowser__BFirm:BPHYT_RS30610 MSAIHPSAAGDPASALYSKLNWRLLPFLVTCYMFAYLDRVNVGFAKLQMQTDLGFSDAAY GVGAGIFFIGYVLFELPSNLMLPKVGARRTFSRILVLWGITSACMLFVRSVPAFYAMRFL LGVFEAGFAPGMIYYLSCWYGPARMARAIALVFVAGPLGGIVGGPVSAWLMTSLSGVGGL AGWQWMFLVEGLPCIALGLLTLRVLSDRPEQARWLNDDEKLLLGRETAPTEHRADSFKAV LKSPRVYVLAFAYFSIIFPIYAISFWLPTLLKEQGVSDTIRLGWYSAIPYVVAAVCMYLA GRSSDRVGERRYHCAIPALGAAICLIAAIFADGNVMLTLTALTLGTACLWMAYTVFWAIP SQLVEGTAAAGGIALINTVGLSGGFWGSAVVGWAKASTGSMHAGLFVMAGAAALAAILIL TGKLTLKQD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server